Baird Medical Investment Holdings Limited (BDMD)
NASDAQ: BDMD · Real-Time Price · USD
1.860
-0.180 (-8.82%)
At close: Aug 1, 2025, 4:00 PM
1.920
+0.060 (3.23%)
After-hours: Aug 1, 2025, 7:54 PM EDT
Company Description
Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People’s Republic of China.
The company offers microwave ablation apparatus and needles; long microwave ablation needles; and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, as well as soft tissue ablation.
It sells its products through third-party distributors. Baird Medical Investment Holdings Limited was founded in 2012 and is based in Guangzhou, China.
Baird Medical Investment Holdings Limited
| Country | China |
| Founded | 2012 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 143 |
| CEO | Haimei Wu |
Contact Details
Address: Baide Building, Building 11, Room 202, 2/F Guangzhou China | |
| Phone | 86 20 8218 5926 |
| Website | bairdmed.com |
Stock Details
| Ticker Symbol | BDMD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001982444 |
| CUSIP Number | G0705H103 |
| ISIN Number | KYG0705H1039 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Haimei Wu | Chairwoman of the Board of Directors and Chief Executive Officer |
| Quan Qiu | Chief Administrative Officer and Executive Director |
| Wei Hou | Executive Director |
| Jie Li | Acting Chief Financial Officer |
| Rongjian Lu | Chief Technology Officer and Deputy GM |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 15, 2025 | 20-F | Annual and transition report of foreign private issuers |
| Apr 30, 2025 | NT 20-F | Notification of inability to timely file Form 20-F |
| Jan 28, 2025 | 6-K | Report of foreign issuer |
| Jan 17, 2025 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Jan 10, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Nov 15, 2024 | F-1 | Registration statement for certain foreign private issuers |
| Nov 1, 2024 | 6-K | Report of foreign issuer |
| Oct 9, 2024 | 20FR12B | Filing |
| Oct 2, 2024 | CERT | Certification by an exchange approving securities for listing |
| Oct 2, 2024 | 6-K | Report of foreign issuer |